BAM
ELAN icon

Belpointe Asset Management’s Elanco Animal Health ELAN Stock Holding History

Belpointe Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-935
Closed -$8.79K – 1357
2023
Q1 		$8.79K Buy
935
+212
+29% +$2.5K ﹤0.01% 2783
2022
Q4 		$8.84K Buy
+723
New +$9.01K ﹤0.01% 2690
2022
Q1 		– Sell
-4,137
Closed -$117K – 1243
2021
Q4 		$117K Sell
4,137
-1,884
-31% -$58.6K 0.01% 1129
2021
Q3 		$192K Sell
6,021
-2,719
-31% -$91.2K 0.01% 875
2021
Q2 		$303K Buy
8,740
+2,065
+31% +$68.1K 0.02% 656
2021
Q1 		$197K Sell
6,675
-3,278
-33% -$101K 0.02% 755
2020
Q4 		$305K Buy
9,953
+162
+2% +$4.94K 0.03% 550
2020
Q3 		$273K Sell
9,791
-4
-0% -$101 0.03% 468
2020
Q2 		$210K Buy
9,795
+1,125
+13% +$24.8K 0.03% 513
2020
Q1 		$194K Buy
8,670
+1,276
+17% +$35K 0.03% 435
2019
Q4 		$218K Buy
+7,394
New +$201K 0.03% 509

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Belpointe Asset Management's ELAN Position: Q2 2023 in Review

Belpointe Asset Management sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 935 shares — an estimated $8.79K sold.

Belpointe Asset Management first reported a position in ELAN in Q4 2019 and held it in 11 quarters. The position peaked at $305K in Q4 2020. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Belpointe Asset Management reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 935 Elanco Animal Health shares in Q2 2023, an estimated $8.79K.
  • Belpointe Asset Management first reported a position in Elanco Animal Health in Q4 2019 and held it in 11 quarters.
  • Belpointe Asset Management's Elanco Animal Health position peaked at $305K in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.